Mark Corbet MacRae Randall
Directeur Général chez Commander Asset Management (Middle East) Ltd.
Profil
Mr. Mark C.
Randall is Chief Executive Officer at Commander Asset Management (Middle East) Ltd.
and Commander Asset Management Ltd.
He and the team formed Commander Asset Management in 2002.
After leaving the Royal Navy, Mr. Randall joined the London office of Bank Sarasin in 1985 and during his 17 year tenure, he held multiple positions within the company.
In 1994, he became an Executive Director before assuming the position of Managing Director.
This role included managing and advising Institutional funds and being responsible for all international securities trading for the Bank Sarasin Group.
He was also founding Chairman of the Acorn Alternative Strategies Overseas Ltd, a Hedge Fund of Fund company which had assets under management in excess of Chf 500 million.
He has held and continues to hold Non-Executive Director roles in both private and publicly quoted companies.
Postes actifs de Mark Corbet MacRae Randall
| Sociétés | Poste | Début |
|---|---|---|
| Commander Asset Management (Middle East) Ltd. | Directeur Général | 01/05/2002 |
Commander Asset Management Ltd.
 Commander Asset Management Ltd. Investment ManagersFinance Commander Asset Management Ltd. (CommanderAM) is an alternative investment firm headquartered in London, UK. The firm was founded by Mark Randall, Timothy Tatham, and James Rolfe in 2002. CommanderAM provides bespoke solutions to institutional investors and other financial institutions to manage or advise segregated accounts, funds, and indexes. | Directeur Général | 01/01/2002 |
Anciens postes connus de Mark Corbet MacRae Randall
| Sociétés | Poste | Fin |
|---|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 04/04/2013 |
| Sarasin International Securities Ltd. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
| Commander Asset Management (Middle East) Ltd. | |
Commander Asset Management Ltd.
Commander Asset Management Ltd. Investment ManagersFinance Commander Asset Management Ltd. (CommanderAM) is an alternative investment firm headquartered in London, UK. The firm was founded by Mark Randall, Timothy Tatham, and James Rolfe in 2002. CommanderAM provides bespoke solutions to institutional investors and other financial institutions to manage or advise segregated accounts, funds, and indexes. | Finance |
| Sarasin International Securities Ltd. | Finance |
